Gregory J. Downing

Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials

Victor G De Gruttola, Pamela Clax, David L. DeMets et al. · Controlled Clinical Trials · 2001 · 423 citations

Pharmacy, Biostatistics, Good Clinical Practice +11

The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health–Centers for Disease Control and Prevention Multidisciplinary Workshop

Muin J. Khoury, Colleen M. McBride, Sheri D. Schully et al. · Genetics in Medicine · 2009 · 197 citations · Full text

Life Sciences, Genetics, Preventive Medicine +6

Wounding of Bioengineered Skin: Cellular and Molecular Aspects After Injury

Vincent Falanga, Cary Isaacs, Dana L. Paquette et al. · Journal of Investigative Dermatology · 2002 · 125 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +14

Characterization of a Soluble Adrenal Phosphatidylinositol 4-Kinase Reveals Wortmannin Sensitivity of Type III Phosphatidylinositol Kinases

Gregory J. Downing, Stanley E. Kim, Satoshi Nakanishi et al. · Biochemistry · 1996 · 120 citations

Life Sciences, Biochemistry, Molecular Biology +14

A Thermodynamic Model for Nap1-Histone Interactions

Andrew J. Andrews, Gregory J. Downing, Kitty Brown et al. · Journal of Biological Chemistry · 2008 · 96 citations · Full text

Life Sciences, Biophysics, Molecular Biology +17